Revivo Therapeutics Overview
- Year Founded
-
2015
- Status
-
Out of Business
- Employees
-
5
- Latest Deal Type
-
Out of Business
Revivo Therapeutics General Information
Description
Operator of a clinical-stage pharmaceutical company intended to target neurobehavioral function, cognitive enhancement, and the reduction of disease progression. The company's therapeutic agents activate multiple key signaling pathways that improve cognitive function and relieve anxiety, enabling doctors to improve memory, reduce behavioral symptoms, and slow down disease progression in Alzheimer's patients.
Contact Information
Website
www.revivotherapeutics.comCorporate Office
- 2530 Meridian Parkway
- Suite 300
- Durham, NC 27713
- United States
Corporate Office
- 2530 Meridian Parkway
- Suite 300
- Durham, NC 27713
- United States
Revivo Therapeutics Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 6. Out of Business | 22-Mar-2025 | Completed | Out of Business | |||
| 5. Later Stage VC | 01-Apr-2024 | Completed | Pre-Clinical Trials | |||
| 4. Debt - General | 10-Jan-2018 | Completed | Pre-Clinical Trials | |||
| 3. Seed Round | 12-Apr-2017 | Completed | Pre-Clinical Trials | |||
| 2. Grant | 12-Dec-2016 | Completed | Pre-Clinical Trials | |||
| 1. Angel (individual) | 24-Aug-2016 | Completed | Pre-Clinical Trials |
Revivo Therapeutics Comparisons
Industry
Financing
Details
Revivo Therapeutics Competitors (1)
One of Revivo Therapeutics’s competitors is Novartis, a Corporation company based in Basel, Switzerland.
| Company Name | Financing Status | Location | Employees | Total Raised | Last Financing Date/Type | Last Financing Amount |
|---|---|---|---|---|---|---|
| Novartis | Corporation | Basel, Switzerland |
Revivo Therapeutics Related Research & Analysis
Explore institutional-grade private market research from our team of analysts.
-
Verticals
Revivo Therapeutics Patents
Revivo Therapeutics Recent Patent Activity
| Publication ID | Patent Title | Status | First Filing Date | Technology (CPC) | Citations |
|---|---|---|---|---|---|
| CA-3128037-A1 | Nomethiazoles as a treatment for rett syndrome | Pending | 01-Feb-2019 | ||
| US-20240024293-A1 | Nomethiazoles as a treatment for rett syndrome | Inactive | 01-Feb-2019 | ||
| WO-2020160541-A1 | Nomethiazoles as a treatment for rett syndrome | Inactive | 01-Feb-2019 | A61K31/426 |
Revivo Therapeutics Signals
Growth Rate
Growth
Size Multiple
Key Data Points
Similarweb Unique Visitors
Majestic Referring Domains
Revivo Therapeutics FAQs
-
When was Revivo Therapeutics founded?
Revivo Therapeutics was founded in 2015.
-
Where is Revivo Therapeutics headquartered?
Revivo Therapeutics is headquartered in Durham, NC.
-
What is the size of Revivo Therapeutics?
Revivo Therapeutics has 5 total employees.
-
What industry is Revivo Therapeutics in?
Revivo Therapeutics’s primary industry is Drug Discovery.
-
Is Revivo Therapeutics a private or public company?
Revivo Therapeutics is a Private company.
-
What is Revivo Therapeutics’s current revenue?
The current revenue for Revivo Therapeutics is .
-
How much funding has Revivo Therapeutics raised over time?
Revivo Therapeutics has raised $250K.
-
Who are Revivo Therapeutics’s competitors?
Novartis is a competitor of Revivo Therapeutics.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process
